This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of pregnant individuals who have OUD and their babies.
Dashboard: Filter Bricks
Main page content
The Advisory outlines the principles and components of low barrier care, and how low barrier care may be leveraged to overcome substantial gaps in access, while also engaging individuals in treatment.
This report provides key findings from the 2022 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment among the noninstitutionalized U.S. population aged 12 or older. Estimates are presented by age group and by race/ethnicity for selected measures.
This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.
This advisory discusses the epidemiology of the mental health symptoms and conditions of Long COVID, provides evidence-based resources for the treatment of those conditions, and offers possible resources.
Read key findings from the 2021 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. Estimates are presented by age group and by race/ethnicity for selected measures. Unlike other NSDUH Annual National Reports, the 2021 report has no discussion of trends over time, because changes in survey methodology mean the indicators are not comparable to past NSDUH estimates.
This Advisory reviews the evidence on prescription stimulant misuse among youth and young adults. It establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, and provides programs and action steps for stakeholders to prevent misuse.
This Advisory, TIP 47, Substance Abuse: Clinical Issues in Intensive Outpatient Treatment, provides an overview of intensive outpatient (IOP) treatment. It discusses typical program goals; outlines key features that improve engagement, retention, and outcomes; and provides additional resources on this critical topic.
This Advisory is based on Technical Assistance Publication (TAP) 21-A, Competencies for Substance Abuse Treatment Clinical Supervisors. It identifies foundational knowledge and concepts essential for supervisory proficiency, roles and skills expected of clinical supervisors, the purpose and context of competencies for supervision in substance use disorder (SUD) treatment programs, and dissemination and implementation of these competencies.
This Advisory, based on Treatment Improvement Protocol (TIP) 54, Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders, is for primary care providers who treat or are likely to treat adult patients with or in recovery from substance use disorders (SUDs) who present with chronic pain. It addresses screening and assessment tools, nonpharmacologic and nonopioid treatment for chronic pain, and the role of opioid therapy in people with chronic noncancer pain and SUDs.
Displaying 1 - 10 out of 41